Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib Trial of Effective-Mononuclear Cell (E-MNC / CA-702) for Radiation-Induced Xerostomia
jRCT2073240123Phase 1Recruiting
- Start
- Mar 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of CA-702 in xerostomia. Primary endpoints: Safety (adverse events and malfunctions), Laboratory test value fluctuations and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
CA-702
03
Conditions
xerostomia
Beyond the preview
Go deeper on jRCT2073240123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2073240123.